Spectrum Pharma (Nasdaq: SPPI) and CASI Pharmaceuticals, Inc. (Nasdaq: CASI) announce the signing of license agreements whereby CASI has been ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE